CHRS vs GE · rev $26.6M vs P/E 44, rev $13.35B
Coherus BioSciences Inc (CHRS) versus GE Aerospace (GE) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported GE revenue for 2026-06-30 was $13.35B. Net income was $2.37B. Revenue was up 7.7% from 2026-03-31 to 2026-06-30. GE currently screens at market cap $373.04B and trailing P/E 44.4.
CHRS currently screens at market cap $223.7M. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Not investment advice. Open the CHRS and GE stock pages for the full models.
Not investment advice.